retatrutide obesity clinical trial results ⭐️topline from TRIUMPH-1, a Phase 3 evaluating #retatrutide, an investigational GIP / GLP-1 / glucagon triple hormone receptor agonist, in adults with or “overweight” Retatrutide Results: 24% Weight Loss
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 1 - Oct 6




















